PL2505195T3 - Kompozycje farmaceutyczne ketoprofenu i metylosulfonylometanu do podawania miejscowego - Google Patents

Kompozycje farmaceutyczne ketoprofenu i metylosulfonylometanu do podawania miejscowego

Info

Publication number
PL2505195T3
PL2505195T3 PL12162459T PL12162459T PL2505195T3 PL 2505195 T3 PL2505195 T3 PL 2505195T3 PL 12162459 T PL12162459 T PL 12162459T PL 12162459 T PL12162459 T PL 12162459T PL 2505195 T3 PL2505195 T3 PL 2505195T3
Authority
PL
Poland
Prior art keywords
methylsulfonylmethane
ketoprofen
pharmaceutical compositions
topical administration
topical
Prior art date
Application number
PL12162459T
Other languages
English (en)
Inventor
Ümit Cifter
Ali Türkyilmaz
Ramazan Önder
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of PL2505195T3 publication Critical patent/PL2505195T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL12162459T 2011-04-01 2012-03-30 Kompozycje farmaceutyczne ketoprofenu i metylosulfonylometanu do podawania miejscowego PL2505195T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/03183A TR201103183A1 (tr) 2011-04-01 2011-04-01 Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
EP12162459.7A EP2505195B1 (en) 2011-04-01 2012-03-30 Topical pharmaceutical compositions of ketoprofen and methylsulfonylmethane

Publications (1)

Publication Number Publication Date
PL2505195T3 true PL2505195T3 (pl) 2014-03-31

Family

ID=45878021

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12162459T PL2505195T3 (pl) 2011-04-01 2012-03-30 Kompozycje farmaceutyczne ketoprofenu i metylosulfonylometanu do podawania miejscowego

Country Status (6)

Country Link
EP (1) EP2505195B1 (pl)
ES (1) ES2444398T3 (pl)
PL (1) PL2505195T3 (pl)
PT (1) PT2505195E (pl)
RS (1) RS53095B (pl)
TR (1) TR201103183A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3319598A4 (en) * 2015-07-08 2019-02-27 Elliptical Therapeutics, LLC IMPROVED TOPICAL KETOPROFEN FORMULATIONS
AU2018376176A1 (en) * 2017-11-30 2020-07-02 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Stable liquid composition of ketoprofen, salts and enantiomers thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4972599A (en) * 1998-07-07 2000-01-24 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
US6399093B1 (en) * 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
US6416772B1 (en) 2001-01-12 2002-07-09 H. Wayne Van Engelen Topical dermal anaesthetic
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
US20050232980A1 (en) * 2004-04-15 2005-10-20 Chen Andrew L Transdermal chondroitin and glucosamine delivery system and method of use
US9616127B2 (en) * 2008-03-11 2017-04-11 Livionex Inc. Method and topical formulation for treating localized edema

Also Published As

Publication number Publication date
EP2505195A1 (en) 2012-10-03
ES2444398T3 (es) 2014-02-24
EP2505195B1 (en) 2013-10-30
PT2505195E (pt) 2013-12-09
TR201103183A1 (tr) 2012-10-22
RS53095B (sr) 2014-06-30

Similar Documents

Publication Publication Date Title
CO6852076A2 (es) Composiciones farmacéuticas inhalables
HRP20150029T1 (xx) Farmaceutski pripravak za lijeäśenje metaboliäśkog sindroma
BR112013012476A2 (pt) formulações farmacêuticas contendo corticosteróides para administração tópica
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
DK2680832T3 (da) Vandig farmaceutisk formulering af tapentadol til oral administration
HUE057510T2 (hu) Félplasztikus gyógyszerészeti dózisegységek elõállítása
LT3222272T (lt) Farmacinė karbetocino kompozicija
EP2758052A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2616076A4 (en) PHARMACEUTICAL COMPOSITIONS
BR112013014644A2 (pt) composição farmacêutica e complexo
ME03483B (me) Amorfni letermovir i njegove čvrste farmaceutske formulacije za oralno davanje
EP2654638A4 (en) COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG
PT2706062T (pt) Novos derivados da cefalosporina e sua composição farmacêutica
DK3156060T3 (da) Farmaceutiske sammensætninger og topisk anvendelse deraf
HRP20181316T1 (hr) Tehnologija isporuke lijeka
HRP20180567T1 (hr) Farmaceutski pripravak omeprazola
FI20125888A7 (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
SMT201500005B (it) Composizione framaceutica inalabile
IL222163B (en) Topical pharmaceutical compositions comprising mometasone furoate
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
BR112013030365A2 (pt) composições para administração percutânea de princípio ativo fisiologicamente
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
CO7000772A2 (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
DK2714042T3 (da) En analgetisk farmaceutisk sammensætning til oral administration